ATLANTA, March 4, 2020 /PRNewswire/ --CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark for the E-vita ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results